Welcome to Medications.com

Analysts expect aggressive guidance from Teva - Globes

Erez also believes that Teva will report 8% growth for the fourth quarter, mostly thanks to its marketing exclusivity for generic Lotrel, the initial launch ...

http://www.globes.co.il/serveen/g... | Posted: Mon Feb 11 12:16:53 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea